Mark Wong Joins Vestaron Corporation's Board of Directors

KALAMAZOO, MI--(Marketwired - January 20, 2016) - Vestaron Corporation is pleased to announce that energy and agriculture entrepreneur Mark Wong will join the Vestaron Board of Directors.

Mr. Wong was an early entrepreneur in plant biotechnology with involvement and leadership in companies that have created more than $1 billion of shareholder value.

Mr. Wong built and sold Agrigenetics, Agracetus and Emergent Genetics, three important firms in the plant biotechnology industry. Currently, Mark is Chairman of Industrial Laboratories and Chairman of TEQ Analytical Labs, as well as a partner of Colorado Financial Holdings, a middle market investor in the dairy and greenhouse industries.

"The power of Vestaron's new class of biological insecticides is truly impressive in its effectiveness over a broad range of insects and its flexibility to be delivered as a spray on product or engineered into the crop plants," said Mr. Wong. "I have never seen a safer product in my 35 years in agriculture. I look forward to participating in the company as a Board Member and investor."

Mr. Wong possesses strong public company experience, being past Chairman of BioFuel Energy and a current member of the Board of Directors of Arcadia Biosciences Inc. and of S&W Seed Company.

"We are honored to have someone as influential and experienced as Mark sitting on Vestaron's board," states Dr. John Sorenson, Vestaron CEO. "We look forward to working with him as Vestaron continues its growth and product research."

Vestaron's SPEAR™ family of bioinsecticides utilizes two new unique modes-of-action with no known resistance. This family of biopesticides is based on natural peptides derived from spider venom, which degrade to useful nutrients in the environment.

About Vestaron Corporation

Vestaron Corporation exploits the natural insecticidal properties of a class of peptides which have potent insect killing potential, but which are safe to humans, birds, fish and the environment.These peptides utilize new modes of action that have never before been used for insect control, and therefore do not suffer from insect resistance. In addition to the bioinsecticides, the Company is also leveraging its peptide technology with the development of traits and synthetics that also have a favorable safety spectrum. In 2015, Vestaron's bioinsecticide technology received the inaugural Bernard Blum Award for Novel Biocontrol Solutions.

Vestaron is a venture-backed company that recently closed an oversubscribed Series C round of financing, totaling $14M.

More information at www.vestaron.com